Optimization of Surgical Treatment for Pediatric Obstructive Sleep Apnea
小儿阻塞性睡眠呼吸暂停手术治疗的优化
基本信息
- 批准号:10687010
- 负责人:
- 金额:$ 19.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:Adenoidal structureAdoptionAffectAnatomyAnestheticsBehaviorBehavioralBlack raceBlindedCardiovascular systemChildChildhoodClinicalClinical InvestigatorClinical TrialsCognitiveConsensusDataDevelopmentDexmedetomidineDiagnosticDrug usageEndoscopyEquipment and supply inventoriesFiber OpticsFrequenciesFunctional disorderFundingGoalsGuidelinesIndividualInternationalInterventionIntravenousKnowledgeLeftLegal patentMeasurementMeasuresMedicineMentored Patient-Oriented Research Career Development AwardMentorshipMorbidity - disease rateNational Heart, Lung, and Blood InstituteNeurocognitiveObesityObstructionObstructive Sleep ApneaOperative Surgical ProceduresOtolaryngologistOutcomeOutcome MeasureOxygenPatient SelectionPatternPharmaceutical PreparationsPhysiologicalPolysomnographyPopulationPositioning AttributePostoperative PeriodPredictive ValuePredictive Value of TestsProceduresPropofolProtocols documentationQuality of lifeQuestionnairesRandomizedRandomized, Controlled TrialsRecommendationRecording of previous eventsRegimenResearchResearch PersonnelResearch TrainingResidual stateResourcesRespondentRiskRisk FactorsSamplingSedation procedureSeriesSeveritiesSiteSleepSleep Apnea SyndromesSoft PalateSpecificityStandardizationSurveysSymptomsTestingTimeTonsilTrainingTranslatingTreatment outcomeVentilatory Depressionagedairway obstructionbehavior rating scalecardiovascular healthcareerdesignexperienceflexibilityhealth care service utilizationimprovedimproved outcomemalignant supraglottis tumorneuromuscularoptical fiberoutcome predictionprimary endpointprospectiverespiratorysecondary endpointsedativeskillssurgery outcometongue roottreatment as usualtrial comparing
项目摘要
PROJECT SUMMARY/ABSTRACT
Obstructive sleep apnea (OSA) affects 1-4% of children, can lead to cognitive, behavioral, and cardiovascular
morbidity, and is associated with a 226% increase in healthcare utilization. Guidelines recommend
adenotonsillectomy (AT) as first-line treatment for pediatric OSA and nearly half a million are performed in U.S.
children annually. However, AT is a one-size-fits-all procedure for a condition with pathophysiology that can
differ dramatically between individuals based on differences in upper airway anatomy and dynamics. These
differences likely account for the high rate of persistent post-AT OSA. Drug-induced sleep endoscopy (DISE)
is a flexible fiber-optic assessment of the upper airway performed under sedation that has potential to direct
individualized surgical treatment and improve outcomes in children with OSA. While early series have
demonstrated good outcomes after DISE-assisted surgery, there is currently no well-controlled, prospective
data to support the use of DISE in children. Prospective research on pediatric DISE has been fundamentally
hindered by the lack of a standardized sedation protocol for the procedure. Choice of sedative may be
important as anesthetic drugs impact upper airway patency to various degrees. Fundamental questions about
how DISE findings should be interpreted and applied cannot be answered without first understanding which
anesthetic facilitates the most useful assessment of upper airway obstruction. The goal of this project is to
determine which anesthetic should be used for DISE. We will perform a randomized controlled trial comparing
the two anesthetic drugs most commonly used to sedate children for the procedure: dexmedetomidine (DEX)
and propofol. The central hypothesis of this proposal is that PROP exaggerates dynamic obstruction
compared to DEX, and thus DISE under DEX provides a more useful and predictive measurement of upper
airway obstruction during sleep. To test this, we will 1) compare mean DISE obstruction scores under sedation
with PROP versus DEX and 2) test the predictive value of obstruction seen on DISE but left untreated by AT
on post-AT outcomes (improvement in symptoms, behavior, quality-of-life, and polysomnography measures)
and need for further treatment for persistent post-AT OSA. To accomplish these aims, Dr. Kirkham will receive
mentorship, focused didactic coursework and training in pediatric sleep medicine and on the design and
implementation of randomized controlled trials. Dr. Kirkham’s long-term goal is to become a leading
independent clinical investigator and expert in the surgical treatment of pediatric OSA. An NHLBI K23 award
will provide Dr. Kirkham with the protected time and needed training to achieve her career goals and improve
outcomes for children with sleep apnea.
项目概要/摘要
阻塞性睡眠呼吸暂停 (OSA) 影响 1-4% 的儿童,可导致认知、行为和心血管疾病
发病率,并且与医疗保健利用率增加 226% 相关。指南推荐
腺样体扁桃体切除术 (AT) 作为儿科 OSA 的一线治疗方法,在美国已实施近 50 万人次。
儿童每年。然而,AT 是一种针对病理生理学病症的万能手术,可以
由于上呼吸道解剖结构和动力学的差异,个体之间存在显着差异。这些
差异可能是 AT 后持续性 OSA 发生率较高的原因。药物诱导睡眠内窥镜检查 (DISE)
是在镇静状态下对上呼吸道进行的灵活光纤评估,有可能指导
个体化手术治疗并改善 OSA 儿童的预后。虽然早期系列有
DISE 辅助手术后显示出良好的结果,但目前尚无良好控制的、前瞻性的
支持在儿童中使用 DISE 的数据。儿科 DISE 的前瞻性研究已从根本上
由于缺乏标准化的镇静方案而受到阻碍。镇静剂的选择可能是
重要的是麻醉药物会不同程度地影响上呼吸道的通畅。有关的基本问题
如果不首先了解哪些内容,就无法回答如何解释和应用 DISE 研究结果
麻醉有助于对上呼吸道阻塞进行最有用的评估。该项目的目标是
确定 DISE 应使用哪种麻醉剂。我们将进行一项随机对照试验来比较
手术中最常用于使儿童镇静的两种麻醉药物: 右美托咪定 (DEX)
和异丙酚。该提案的中心假设是 PROP 夸大了动态阻碍
与 DEX 相比,因此 DEX 下的 DISE 提供了更有用和更具预测性的上层测量
睡眠时气道阻塞。为了测试这一点,我们将 1) 比较镇静状态下的平均 DISE 阻塞评分
使用 PROP 与 DEX 进行比较,以及 2) 测试在 DISE 上发现但未经 AT 治疗的阻塞的预测价值
AT 后结果(症状、行为、生活质量和多导睡眠图测量的改善)
并需要进一步治疗持续性 AT 后 OSA。为了实现这些目标,柯卡姆博士将获得
儿科睡眠医学以及设计和治疗方面的指导、重点教学课程和培训
实施随机对照试验。 Kirkham 博士的长期目标是成为领先的
儿科 OSA 手术治疗的独立临床研究者和专家。 NHLBI K23 奖项
将为 Kirkham 博士提供受保护的时间和所需的培训,以实现她的职业目标并提高
患有睡眠呼吸暂停的儿童的结果。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Preoperative Predictors of Severe Respiratory Events After Tonsillectomy: Consideration for Pediatric Intensive Care Admission.
扁桃体切除术后严重呼吸事件的术前预测因素:考虑儿科重症监护入院。
- DOI:10.1002/ohn.238
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Kirkham,ErinM;Puglia,MichaelP;Haydar,Bishr;Jewell,ElizabethS;Leis,AledaM;Peddireddy,Nithin;Chervin,RonaldD
- 通讯作者:Chervin,RonaldD
Adenotonsillectomy for Snoring and Mild Sleep Apnea in Children: A Randomized Clinical Trial.
腺样体扁桃体切除术治疗儿童打鼾和轻度睡眠呼吸暂停:一项随机临床试验。
- DOI:10.1001/jama.2023.22114
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Redline,Susan;Cook,Kaitlyn;Chervin,RonaldD;Ishman,Stacey;Baldassari,CristinaM;Mitchell,RonB;Tapia,IgnacioE;Amin,Raouf;Hassan,Fauziya;Ibrahim,Sally;Ross,Kristie;Elden,LisaM;Kirkham,ErinM;Zopf,David;Shah,Jay;Otteson,Todd
- 通讯作者:Otteson,Todd
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erin Marie Kirkham其他文献
Erin Marie Kirkham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erin Marie Kirkham', 18)}}的其他基金
Optimization of Surgical Treatment for Pediatric Obstructive Sleep Apnea
小儿阻塞性睡眠呼吸暂停手术治疗的优化
- 批准号:
10301406 - 财政年份:2021
- 资助金额:
$ 19.26万 - 项目类别:
Optimization of Surgical Treatment for Pediatric Obstructive Sleep Apnea
小儿阻塞性睡眠呼吸暂停手术治疗的优化
- 批准号:
10478086 - 财政年份:2021
- 资助金额:
$ 19.26万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 19.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 19.26万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 19.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.26万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 19.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.26万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 19.26万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 19.26万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 19.26万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 19.26万 - 项目类别:
Standard Grant














{{item.name}}会员




